相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The genome as a record of environmental exposure
Serena Nik-Zainal et al.
MUTAGENESIS (2015)
The Hepatic Reductase Null (HRN™) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants
Volker M. Arlt et al.
TOXICOLOGY RESEARCH (2015)
The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats
Marie Stiborova et al.
ARCHIVES OF TOXICOLOGY (2015)
Flexible Docking-Based Molecular Dynamics/Steered Molecular Dynamics Calculations of Protein-Protein Contacts in a Complex of Cytochrome P450 1A2 with Cytochronne b5
Petr Jerabek et al.
BIOCHEMISTRY (2014)
Exceptionally long- term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy
Heinz H. Schmeiser et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Mechanisms of Enzyme-Catalyzed Reduction of Two Carcinogenic Nitro-Aromatics, 3-Nitrobenzanthrone and Aristolochic Acid I: Experimental and Theoretical Approaches
Marie Stiborova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Mitochondrial Targeting of Cytochrome P450 (CYP) 1B1 and Its Role in Polycyclic Aromatic Hydrocarbon- induced Mitochondrial Dysfunction*
Seema Bansal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats
Marie Stiborova et al.
MUTAGENESIS (2014)
The effect of aristolochic acid I on expression of NAD(P)H:quinone oxidoreductase in mice and rats-A comparative study
Frantisek Barta et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2014)
Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid
Marie Stiborova et al.
XENOBIOTICA (2014)
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy A Narrative Review
M. Refik Goekmen et al.
ANNALS OF INTERNAL MEDICINE (2013)
Enzymes Metabolizing Aristolochic Acid and their Contribution to the Development of Aristolochic Acid Nephropathy and Urothelial Cancer
Marie Stiborova et al.
CURRENT DRUG METABOLISM (2013)
Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism
Agnes A. Walsh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Song Ling Poon et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing
Margaret L. Hoang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Evidence That Cytochrome b5 and Cytochrome b5 Reductase Can Act as Sole Electron Donors to the Hepatic Cytochrome P450 Systems
Colin J. Henderson et al.
MOLECULAR PHARMACOLOGY (2013)
Biomonitoring of Aristolactam-DNA Adducts in Human Tissues Using Ultra-Performance Liquid Chromatography/Ion-Trap Mass Spectrometry
Byeong Hwa Yun et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Cytochrome b5 Increases Cytochrome P450 3A4-Mediated Activation of Anticancer Drug Ellipticine to 13-Hydroxyellipticine Whose Covalent Binding to DNA Is Elevated by Sulfotransferases and N,O-Acetyltransferases
Marie Stiborova et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania
Heinz H. Schmeiser et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2012)
Aristolochic acid-associated urothelial cancer in Taiwan
Chung-Hsin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Bioactivation versus Detoxication of the Urothelial Carcinogen Aristolochic Acid I by Human Cytochrome P450 1A1 and 1A2
Marie Stiborova et al.
TOXICOLOGICAL SCIENCES (2012)
Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5
Marie Stiborova et al.
TOXICOLOGY (2012)
NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I
Katerina Levova et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats
Alice Zacharova et al.
XENOBIOTICA (2012)
Cytochrome b5 shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy
Vera Kotrbova et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat
Rostislav Vecera et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2011)
Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) Mice
Volker M. Arlt et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
The Human Carcinogen Aristolochic Acid I Is Activated to Form DNA Adducts by Human NAD(P)H:quinone Oxidoreductase Without the Contribution of Acetyltransferases or Sulfotransferases
Marie Stiborova et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2011)
Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model
Katerina Levova et al.
TOXICOLOGICAL SCIENCES (2011)
Inhibition of Renal NQO1 Activity by Dicoumarol Suppresses Nitroreduction of Aristolochic Acid I and Attenuates its Nephrotoxicity
Min Chen et al.
TOXICOLOGICAL SCIENCES (2011)
Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse
Thomas A. Rosenquist et al.
DRUG METABOLISM AND DISPOSITION (2010)
Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model
Jill E. Kucab et al.
FEBS JOURNAL (2010)
Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents
Shinya Shibutani et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Deletion of Microsomal Cytochrome b5 Profoundly Affects Hepatic and Extrahepatic Drug Metabolism
Lesley A. McLaughlin et al.
MOLECULAR PHARMACOLOGY (2010)
TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours
Tatiana Nedelko et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Linear Energy Relationships for the Octahedral Preference of Mg, Ca and Transition Metal Ions
George Pontikis et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2009)
Preparation of a biologically active apo-cytochrome b5 via heterologous expression in Escherichia coli
Vera Kotrbova et al.
PROTEIN EXPRESSION AND PURIFICATION (2009)
Defining the in Vivo Role for Cytochrome b5 in Cytochrome P450 Function through the Conditional Hepatic Deletion of Microsomal Cytochrome b5
Robert D. Finn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity
Y Xiao et al.
KIDNEY INTERNATIONAL (2008)
Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid
M. Stiborova et al.
KIDNEY INTERNATIONAL (2008)
Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy
Marie Stiborova et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury
Xiang Xue et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Aristolochic acid mutagenesis:: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer
Volker M. Arlt et al.
CARCINOGENESIS (2007)
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
Arthur P. Grollman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2
Stefaan Sansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A semiempirical free energy force field with charge-based desolvation
Ruth Huey et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2007)
Rat cytochrome P4502C11 in liver microsomes involved in oxidation of anesthetic agent propofol and deactivated by prior treatment with propofol
Hiroshi Yamazaki et al.
DRUG METABOLISM AND DISPOSITION (2006)
Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry
Wan Chan et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen
M Stiborová et al.
CANCER LETTERS (2005)
Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers
M Stiborová et al.
CANCER LETTERS (2005)
Human hepatic and renal microsomes, Cytochromes P450 1A1/2, NADPH:Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer
M Stiborová et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy
GM Lord et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid:: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase
M Stiborová et al.
CARCINOGENESIS (2003)
The many roles of cytochrome b5
JB Schenkman et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?
VM Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
VM Arlt et al.
MUTAGENESIS (2002)
Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy
M Stiborová et al.
CARCINOGENESIS (2002)
Stimulation of cytochrome P450 reactions by apo-cytochrome b5 -: Evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5, or heme oxygenase
H Yamazaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids:: Evidence for reductive activation by cytochromes P450 1A1 and 1A2
M Stiborová et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
